BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10469175)

  • 1. Desmopressin in the treatment of women's bleeding disorders.
    Lethagen S
    Haemophilia; 1999 Jul; 5(4):233-7. PubMed ID: 10469175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do you treat bleeding disorders with desmopressin?
    Ozgönenel B; Rajpurkar M; Lusher JM
    Postgrad Med J; 2007 Mar; 83(977):159-63. PubMed ID: 17344569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin (DDAVP) and hemostasis.
    Lethagen S
    Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
    Lethagen S; Ragnarson Tennvall G
    Ann Hematol; 1993 May; 66(5):257-60. PubMed ID: 8507721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin analogues. Their role in disorders of hemostasis.
    Mannuccio PM; Altieri D; Faioni E
    Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
    Sharma R; Stein D
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
    Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
    Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.
    Svensson PJ; Bergqvist PB; Juul KV; Berntorp E
    Blood Rev; 2014 May; 28(3):95-102. PubMed ID: 24703870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
    Gill JC; Ottum M; Schwartz B
    J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menorrhagia and bleeding disorders in adolescent females.
    Halimeh S
    Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin.
    Rodeghiero F
    Haemophilia; 2008 Jan; 14 Suppl 1():21-30. PubMed ID: 18173691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.